B7 H6 (NCR3LG1) Human Gene Knockout Kit (CRISPR)
CAT#: KN232774RB
NCR3LG1 - human gene knockout kit via CRISPR, HDR mediated
HDR-mediated knockout kit validation
Product Images
Specifications
| Product Data | |
| Format | 2 gRNA vectors, 1 RFP-BSD donor, 1 scramble control |
| Donor DNA | RFP-BSD |
| Symbol | B7 H6 |
| Locus ID | 374383 |
| Components | KN232774G1, B7 H6 gRNA vector 1 in pCas-Guide CRISPR vector KN232774G2, B7 H6 gRNA vector 2 in pCas-Guide CRISPR vector KN232774RBD, donor DNA containing left and right homologous arms and RFP-BSD functional cassette. GE100003, scramble sequence in pCas-Guide vector |
| Disclaimer | These products are manufactured and supplied by OriGene under license from ERS. The kit is designed based on the best knowledge of CRISPR technology. The system has been functionally validated for knocking-in the cassette downstream the native promoter. The efficiency of the knock-out varies due to the nature of the biology and the complexity of the experimental process. |
| Reference Data | |
| RefSeq | NM_001202439, NM_001009913, NR_026750 |
| UniProt ID | Q68D85 |
| Synonyms | B7-H6; B7H6; DKFZp686O24166 |
| Summary | B7H6 belongs to the B7 family (see MIM 605402) and is selectively expressed on tumor cells. Interaction of B7H6 with NKp30 (NCR3; MIM 611550) results in natural killer (NK) cell activation and cytotoxicity (Brandt et al., 2009 [PubMed 19528259]).[supplied by OMIM, Jan 2011] |
Documents
| Product Manuals |
| FAQs |
|
| SDS |
Resources
Other Versions
| SKU | Description | Size | |
|---|---|---|---|
| KN232774 | NCR3LG1 - human gene knockout kit via CRISPR, HDR mediated | 1 657,00 EUR | |
| KN232774BN | NCR3LG1 - human gene knockout kit via CRISPR, HDR mediated | 1 657,00 EUR | |
| KN232774LP | NCR3LG1 - human gene knockout kit via CRISPR, HDR mediated | 1 657,00 EUR | |
| KN432774 | NCR3LG1 - KN2.0, Human gene knockout kit via CRISPR, non-homology mediated. | 1 657,00 EUR | |
| GA117762 | NCR3LG1 CRISPRa kit - CRISPR gene activation of human natural killer cell cytotoxicity receptor 3 ligand 1 | 1 657,00 EUR |